Richard Peltier
Papers
1
Total Citations
39
H-Index
1
About
Richard Peltier is a neuroscientist whose research focuses on the molecular pharmacology of metabotropic glutamate receptors (mGluRs) and their role in central nervous system disorders. His major contribution lies in pioneering automated high-throughput screening (HTS) methodologies to identify novel mGluR antagonists, a critical step toward developing therapeutic agents for conditions like anxiety, schizophrenia, and chronic pain. His landmark 2003 paper, "Identification of metabotropic glutamate receptor antagonists using an automated high-throughput screening system," has garnered 39 citations, establishing a foundational approach for drug discovery in this field. Peltier’s work bridges the gap between basic receptor biology and translational medicine, enabling the rapid evaluation of chemical libraries to target specific mGluR subtypes. By integrating robotics and assay miniaturization, he has advanced the efficiency of pharmacological screening, influencing subsequent studies on glutamatergic signaling. His achievements underscore a commitment to accelerating the pipeline from bench to bedside, making him a key figure in neuropharmacology for students and researchers exploring G protein-coupled receptor drug development.
Research Focus
Key Achievements
Top Papers
- 1